These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

395 related items for PubMed ID: 30223711

  • 21. Aspects of speech rate and regularity in Parkinson's disease.
    Skodda S.
    J Neurol Sci; 2011 Nov 15; 310(1-2):231-6. PubMed ID: 21849174
    [Abstract] [Full Text] [Related]

  • 22. [F0 characteristics in Parkinsonian speech: Contrast between the effect of hypodopaminergy due to Parkinson's disease and that of the therapeutic delivery of L-Dopa].
    Ghio A, Robert D, Grigoli C, Mas M, Delooze C, Mercier C, Viallet F.
    Rev Laryngol Otol Rhinol (Bord); 2014 Nov 15; 135(2):63-70. PubMed ID: 26521344
    [Abstract] [Full Text] [Related]

  • 23. Effects of dopaminergic replacement therapy on motor speech disorders in Parkinson's disease: longitudinal follow-up study on previously untreated patients.
    Rusz J, Tykalová T, Klempíř J, Čmejla R, Růžička E.
    J Neural Transm (Vienna); 2016 Apr 15; 123(4):379-87. PubMed ID: 26843071
    [Abstract] [Full Text] [Related]

  • 24. Surgical approaches to treatment of Parkinson's disease: Implications for speech function.
    Murdoch BE.
    Int J Speech Lang Pathol; 2010 Oct 15; 12(5):375-84. PubMed ID: 20602579
    [Abstract] [Full Text] [Related]

  • 25. Acoustic investigation of stress patterns in Parkinson's disease.
    Tykalova T, Rusz J, Cmejla R, Ruzickova H, Ruzicka E.
    J Voice; 2014 Jan 15; 28(1):129.e1-129.e8. PubMed ID: 24094802
    [Abstract] [Full Text] [Related]

  • 26. Deficits in monitoring self-produced speech in Parkinson's disease.
    Railo H, Nokelainen N, Savolainen S, Kaasinen V.
    Clin Neurophysiol; 2020 Sep 15; 131(9):2140-2147. PubMed ID: 32682241
    [Abstract] [Full Text] [Related]

  • 27. ParkinSong: A Controlled Trial of Singing-Based Therapy for Parkinson's Disease.
    Tamplin J, Morris ME, Marigliani C, Baker FA, Vogel AP.
    Neurorehabil Neural Repair; 2019 Jun 15; 33(6):453-463. PubMed ID: 31081485
    [Abstract] [Full Text] [Related]

  • 28. Effect of speech therapy and pharmacological treatment in prosody of parkinsonians.
    Azevedo LL, Souza IS, Oliveira PM, Cardoso F.
    Arq Neuropsiquiatr; 2015 Jan 15; 73(1):30-5. PubMed ID: 25608124
    [Abstract] [Full Text] [Related]

  • 29. The impact of Parkinson's disease on vocal-prosodic communication from the perspective of listeners.
    Pell MD, Cheang HS, Leonard CL.
    Brain Lang; 2006 May 15; 97(2):123-34. PubMed ID: 16226803
    [Abstract] [Full Text] [Related]

  • 30. The effect of increased vocal intensity on interarticulator timing in speakers with Parkinson’s disease: a preliminary analysis.
    Richardson K, Sussman JE, Stathopoulos ET.
    J Commun Disord; 2014 May 15; 52():44-64. PubMed ID: 25459460
    [Abstract] [Full Text] [Related]

  • 31. Bilateral subthalamic stimulation effects on oral force control in Parkinson's disease.
    Pinto S, Gentil M, Fraix V, Benabid AL, Pollak P.
    J Neurol; 2003 Feb 15; 250(2):179-87. PubMed ID: 12574948
    [Abstract] [Full Text] [Related]

  • 32. Perceptive and subjective evaluation of speech disorders in Parkinson's disease.
    Melchionda D, Varvara G, Perfetto D, Mascolo B, Avolio C.
    J Biol Regul Homeost Agents; 2020 Feb 15; 34(2):683-686. PubMed ID: 32475102
    [Abstract] [Full Text] [Related]

  • 33. Hypokinetic Dysarthria in Parkinson's Disease: A Narrative Review.
    Atalar MS, Oguz O, Genc G.
    Sisli Etfal Hastan Tip Bul; 2023 Feb 15; 57(2):163-170. PubMed ID: 37899809
    [Abstract] [Full Text] [Related]

  • 34. Parkinson's disease or atypical parkinsonism? The importance of acoustic voice analysis in differential diagnosis of speech disorders.
    Kowalska-Taczanowska R, Friedman A, Koziorowski D.
    Brain Behav; 2020 Aug 15; 10(8):e01700. PubMed ID: 32525283
    [Abstract] [Full Text] [Related]

  • 35. Articulation Features of Parkinson's Disease Patients with Subthalamic Nucleus Deep Brain Stimulation.
    Tanaka Y, Tsuboi T, Watanabe H, Kajita Y, Nakatsubo D, Fujimoto Y, Ohdake R, Ito M, Atsuta N, Yamamoto M, Wakabayashi T, Katsuno M, Sobue G.
    J Parkinsons Dis; 2016 Oct 19; 6(4):811-819. PubMed ID: 27662325
    [Abstract] [Full Text] [Related]

  • 36. Towards an automatic evaluation of the dysarthria level of patients with Parkinson's disease.
    Vásquez-Correa JC, Orozco-Arroyave JR, Bocklet T, Nöth E.
    J Commun Disord; 2018 Oct 19; 76():21-36. PubMed ID: 30149241
    [Abstract] [Full Text] [Related]

  • 37. A Methodology to Differentiate Parkinson's Disease and Aging Speech Based on Glottal Flow Acoustic Analysis.
    Gómez-Rodellar A, Palacios-Alonso D, Ferrández Vicente JM, Mekyska J, Álvarez-Marquina A, Gómez-Vilda P.
    Int J Neural Syst; 2020 Oct 19; 30(10):2050058. PubMed ID: 32880202
    [Abstract] [Full Text] [Related]

  • 38. Treatment of articulatory dysfunction in Parkinson's disease using repetitive transcranial magnetic stimulation.
    Murdoch BE, Ng ML, Barwood CH.
    Eur J Neurol; 2012 Feb 19; 19(2):340-7. PubMed ID: 21967191
    [Abstract] [Full Text] [Related]

  • 39. [A case of Parkinson's disease treated effectively with a pacing board for repetitive speech phenomena after deep brain stimulation].
    Suzuki J, Tanaka Y, Watanabe H, Ito M, Kajita Y, Sobue G.
    Rinsho Shinkeigaku; 2013 Feb 19; 53(4):304-7. PubMed ID: 23603546
    [Abstract] [Full Text] [Related]

  • 40. [Acoustic analysis of prosody in females with Parkinson's disease: comparison with normal controls].
    Azevedo LL, Cardoso F, Reis C.
    Arq Neuropsiquiatr; 2003 Dec 19; 61(4):999-1003. PubMed ID: 14762606
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.